US OptionsDetailed Quotes

NNVC240719P2500

Watchlist
  • 0.35
  • 0.000.00%
15min DelayTrading Jul 18 10:30 ET
0.00High0.00Low

Nanoviricides Stock Discussion

Sign in to post a comment
    The Thinker
    The Thinker
    Jul 17 19:52
    Dow Hits Record High as Tech Stocks Tumble
    Follow Our Official Telegram Channel tynkrlab
    $Dow Jones Industrial Average(.DJI.US)$ rose by 0.59% to a new record high, closing at 41,211.12. In contrast, the $S&P 500 Index(.SPX.US)$ fell by 1.39%, and the $Nasdaq Composite Index(.IXIC.US)$ dropped by 2.76%. Tech stocks faced significant pressure, contributing to the mixed market performance.
    Key Drivers
    1. Strong Performers: $UnitedHealth(UNH.US)$, $Johnson & Johnson(JNJ.US)$, and $Cisco(CSCO.US)$ l...
    Dow Hits Record High as Tech Stocks Tumble
    Jaguar8
    Jaguar8
    Jul 11 06:26
    NEWS
    $Nanoviricides(NNVC.US)$
    A Single Drug Against Multiple Respiratory Virus Infections - COVID, RSV, Influenza, Bird Flu - Planning Next Phase of Clinical Trials, Says NanoViricides
    NanoViricides discusses its development of NV-387, a drug targeting multiple respiratory viruses including COVID, RSV, Influenza, and Bird Flu.
    NV-387 has shown superior activity in animal models compared to approved drugs and has completed Phase I trials with no adverse events.
    The company is planning Phase II tri...
    Jaguar8
    Jaguar8
    Jul 1 07:41
    NEWS
    $Nanoviricides(NNVC.US)$
    NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections
    NanoViricides, a leader in antiviral nanomedicines, presents the progress of its drug candidate NV-387, which has completed Phase I clinical trials with no adverse events reported. NV-387 has demonstrated significant efficacy against various viruses, including RSV, Influenza, ...
    Mcsnacks H Tupack
    Mcsnacks H Tupack
    Jun 24 05:14
    More news but no reaction
    $Nanoviricides(NNVC.US)$ A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1
    Trytosaveabit
    Trytosaveabit
    Jun 20 05:45
    Update
    $Nanoviricides(NNVC.US)$ Nanoviricides Reports That The Ultra-broad-spectrum Antiviral NV-387, A Phase 2 Stage Drug Candidate, Was Found To Be Effective In Protecting Lungs From Damage In A Lethally Infected Influenza H3N2 Mouse Model
    2
    Trytosaveabit
    Trytosaveabit
    Jun 11 12:22
    Not just the PPS!
    $Nanoviricides(NNVC.US)$ Yes a beautiful uptrend overall since mid/late April. But more, very encouraging data for NV-387! A statement said a few months ago with results and data from early testing, that this could be the biggest thing in medicine since antibiotics. Well that would be amazing yes for stock price! But what that could mean for disease treatment overall could be a game changer? The early data seems that its still on that path.🤞❤️
    4
    Jaguar8
    Jaguar8
    Jun 4 05:34
    NEWS
    $Nanoviricides(NNVC.US)$
    The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect
    NanoViricides announced a significant advancement in its lead antiviral agent, NV-387. This drug, designed for broad-spectrum antiviral treatment, has shown prolonged blood concentration levels in non-human primate models, indicating the potential for infrequent dosing. NV-387's unique polymeric design helps sustain drug levels, making it effecti...
    Jaguar8
    Jaguar8
    May 29 06:20
    NEWS
    $Nanoviricides(NNVC.US)$
    A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
    NanoViricides, a leader in broad-spectrum antiviral nanomedicines, has developed NV-387, a first-in-class antiviral agent targeting RSV, COVID-19, Influenza, and other viruses. NV-387 employs novel host-mimetic technology to remain effective despite viral mutations. It has outperformed existing drugs such as remdesivir, T...
    Jaguar8
    Jaguar8
    May 23 07:40
    $Nanoviricides(NNVC.US)$
    NEWS
    NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc
    NanoViricides has engaged Aagami Inc. to seek licensing and partnering opportunities for its key asset, NV-387, and platform technology in India and Japan. NV-387, a broad-spectrum antiviral nanomedicine, has completed Phase I clinical trials in healthy subjects with no adverse effects reported. It is now ready for Phase II trials.
    NV-387, designed to mimic host-side virus-binding features, targets a wi...

No comment yet